Advertisement

Topics

Inovio Pharma Reports Promising Phase 1b Clinical Trial Data Of INO-5150

08:32 EDT 11 Sep 2017 | FinanzNachrichten

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Inovio Pharmaceuticals, Inc. (INO) announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8...

Original Article: Inovio Pharma Reports Promising Phase 1b Clinical Trial Data Of INO-5150

NEXT ARTICLE

More From BioPortfolio on "Inovio Pharma Reports Promising Phase 1b Clinical Trial Data Of INO-5150"

Quick Search
Advertisement
 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...